A major leadership change can quickly shift the conversation around a stock, and that is exactly what we have with Boston Scientific (BSX) this week. With news that Jeffrey B. Mirviss, Executive Vice ...
Boston Scientific Corporation recently announced that Jeffrey B. Mirviss, Executive Vice President and President of Peripheral Interventions, will retire effective December 1, 2025, and serve as a ...
In the latest quarter, 9 analysts provided ratings for Boston Scientific (NYSE:BSX), showcasing a mix of bullish and bearish perspectives. The following table provides a quick overview of their recent ...
Boston Scientific Corporation (NYSE:BSX) is one of the best beginner stocks to buy, according to analysts. On September 11, analysts at Needham reiterated a ‘Buy’ rating on the stock and a $121 price ...
Boston Scientific has agreed to buy Elutia's bioenvelopes, which protect patients receiving implantable medical devices, for $88 million in cash. Elutia said the deal will allow it to eliminate debt, ...
Investing.com -- Oppenheimer analysts shifted ratings on U.S. medical device makers, lifting Boston Scientific to Outperform while cutting rating on DexCom to Perform. Boston Scientific was upgraded ...
1don MSN
Software tool helps scientists interpret complex spatial data across healthy and diseased tissue
Researchers at the Icahn School of Medicine at Mount Sinai in New York, Boston Medical Center, and Boston University ...
BOSTON, MA / ACCESS Newswire / September 10, 2025 / Leading up to Boston Fintech Week 2025 presented by Fintech Sandbox, Mass Fintech Hub has announced plans to host four in-person events that will ...
Nuclear fusion promises a green and infinitely renewable supply of energy—if we can harness it. Fusion happens all the time inside the sun. But to recreate the process on Earth, we must control ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback